EMA: Update of the Annex to the Excipients Guideline
Recommendation

10/11 February 2026
Risk analysis, preventive measures and incident management
In April 2024, the fourth revision of the Annex to the Guideline "Excipients in the labeling and package leaflet of medicinal products for human use" was published on the EMA website. The guideline, which has been available in the currently applicable version since March 2018, consists of the following chapters:
- INTRODUCTION
- PURPOSE
- DEFINITIONS AND EXAMPLES
- NOMENCLATURE
- EXCIPIENTS IN THE LABELLING
- EXCIPIENTS IN THE PACKAGE LEAFLET
- ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET
Now the annex "EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" has been revised again and the information for polysorbates has been listed. The substances are listed in the annex in tabular and alphabetical order and the corresponding texts for the package leaflet are given. Furthermore, additional comments as well as the type of application and the corresponding threshold values are listed together with the update date.
The current version of the guideline "Excipients in the labeling and package leaflet of medicinal products for human use" and the "ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" can be found on the EMA website.
Related GMP News
28.01.2026IPEC: Revised REACH Guide for Excipients
28.01.2026EDQM: New General Chapter 'Quality of Data' available
21.01.2026FDA Warning Letter: Q-Unit failed to document API release
14.01.2026Testing for ethylene glycol, diethylene glycol and methanol – a hot topic during FDA inspections
14.01.2026APIC: Update to the Data Integrity FAQs


